ADCY5 and drug-induced dyskinesia: The constellation of neurological disorders associated with ADCY5 mutations includes conditions of variable severity, ranging from severe early-onset neurodevelopmental disorder with dyskinesia to familial dyskinesia with facial myokymia (FDFM).